↓ Skip to main content

HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas

Overview of attention for article published in Journal of Hematology & Oncology, September 2012
Altmetric Badge

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
Published in
Journal of Hematology & Oncology, September 2012
DOI 10.1186/1756-8722-5-57
Pubmed ID
Authors

Angela M Sosin, Angelika M Burger, Aisha Siddiqi, Judith Abrams, Ramzi M Mohammad, Ayad M Al-Katib

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 4%
Unknown 27 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 25%
Student > Ph. D. Student 6 21%
Researcher 5 18%
Student > Master 3 11%
Other 2 7%
Other 3 11%
Unknown 2 7%
Readers by discipline Count As %
Chemistry 8 29%
Agricultural and Biological Sciences 7 25%
Medicine and Dentistry 4 14%
Biochemistry, Genetics and Molecular Biology 2 7%
Nursing and Health Professions 1 4%
Other 4 14%
Unknown 2 7%